Key Findings:  This study aimed to assess the safety and efficacy of cannabidiol use in patients with autism spectrum disorder (ASD) and found it to be safe and supports its potential therapeutic use, however long-term safety evidence was lacking.
Type of Study:  Meta-analysis
Study Sample Size:  188
Study Result:  Positive
Study Location(s):  United States
Year of Pub:  2020
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype III